Evidence map›Paper›PMID 33902268›Full record

ArticleIntestinal research2022

Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report.

Miki Koroku, Teppei Omori, Harutaka Kambayashi, Shun Murasugi, Tomoko Kuriyama, Yuichi Ikarashi, Maria Yonezawa, Ken Arimura, Kazunori Karasawa, Norio Hanafusa and 2 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Intestinal research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Miki KorokuInstitute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
Teppei OmoriInstitute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
Harutaka KambayashiInstitute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
Shun MurasugiInstitute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
Tomoko KuriyamaInstitute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
Yuichi IkarashiInstitute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
Maria YonezawaInstitute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
Ken ArimuraDepartment of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Kazunori KarasawaDivision of Nephrology, Department of Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Norio HanafusaDepartment of Blood Purification, Tokyo Women's Medical University, Tokyo, Japan.
Masatoshi KawanaPrimary Care Center, Tokyo Women's Medical University, Tokyo, Japan.
Katsutoshi TokushigeInstitute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
Tokyo Women's Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now a pandemic. Although several treatment guidelines have been proposed for patients who have both inflammatory bowel disease and COVID-19, immunosuppressive therapy is essentially not recommended, and the treatment options are limited. Even in the COVID-19 pandemic, adjuvant adsorptive granulocyte and monocyte apheresis may safely bring ulcerative colitis (UC) into remission by removing activated myeloid cells without the use of immunosuppressive therapy. Our patient was a 25-year-old Japanese male with UC and COVID-19. This is the first case report of the induction of UC remission with granulocyte and monocyte apheresis treatment for active UC associated with COVID-19.

Indexed as

Case reportsCOVID-19Granulocyte and monocyte adsorptive apheresisUlcerative colitis

Identifiers

PMID33902268
PMCPMC8831771
OpenAlexW3135270017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.